Dr. Oz prevails in Pennsylvania primary after McCormick concedes
Former hedge fund executive David McCormick surrendered to Dr. Mehmet Oz in Pennsylvania's Republican Senate primary on Friday, catapulting the former President Trump-backed Oz to a general election standoff against Democrat Lt. Gov. John Fetterman.
The two Republican candidates had been locked in a tight contest for weeks, after Oz's ever-so-slight lead in the race triggered a recount. "It's now clear to me, with the recount largely complete, that we have a nominee," McCormick said Friday. Oz later said he received a "gracious" phone call from McCormick, and is "tremendously grateful for his pledge of support in the fall election."
"Now that our primary is over, we will make sure that this U.S. Senate seat does not fall into the hands of the radical left, led by John Fetterman," Oz continued.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Fetterman, who is currently recovering from a stroke, had an easy time clinching the Democratic nomination against his most notable opponent, U.S. Rep. Conor Lamb. On the Republican side, the closely-watched Senate primary had been viewed as a barometer for Trump's continued influence over the GOP — thus rendering Oz's victory all the more significant.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.
-
6 homes for entertainingFeature Featuring a heated greenhouse in Pennsylvania and a glamorous oasis in California
-
Obesity drugs: Will Trump’s plan lower costs?Feature Even $149 a month, the advertised price for a starting dose of a still-in-development GLP-1 pill on TrumpRx, will be too big a burden for the many Americans ‘struggling to afford groceries’
-
The ‘Kavanaugh stop’Feature Activists say a Supreme Court ruling has given federal agents a green light to racially profile Latinos
-
Affordability: Does Trump have an answer?Feature Trump ‘refuses to admit there is a problem’
-
Ecuador rejects push to allow US military basesSpeed Read Voters rejected a repeal of a constitutional ban on US and other foreign military bases in the country
-
Trump pivots on Epstein vote amid GOP defectionsSpeed Read The president said House Republicans should vote on a forced release of the Justice Department’s Jeffrey Epstein files
-
Is Marjorie Taylor Greene undergoing a political realignment?TALKING POINTS The MAGA firebrand made a name for herself in Congress as one of Trump’s most unapologetic supporters. One year into Trump’s second term, a shift is afoot.
-
How are these Epstein files so damaging to Trump?TODAY'S BIG QUESTION As Republicans and Democrats release dueling tranches of Epstein-related documents, the White House finds itself caught in a mess partially of its own making
-
Will California tax its billionaires?Talking Points A proposed one-time levy would shore up education and Medicaid
-
Trump DOJ sues to block California redistrictingSpeed Read California’s new congressional map was drawn by Democrats to flip Republican-held House seats
-
GOP retreats from shutdown deal payout provisionSpeed Read Senators are distancing themselves from a controversial provision in the new government funding package
